Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Nishida

Showing results (71-80 of 164) with videos related to

Pageof 17
Sort By:
Blood Advances|March 20, 2020
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantationSatoshi Kaito, Yujiro Nakajima, Konan Hara, et al.
British Journal of Haematology|October 20, 2025
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCTTomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, et al.
Plos One|September 26, 2017
High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotypeDaisuke Koyama, Makoto Murata, Ryo Hanajiri, et al.
Transplantation and Cellular Therapy|September 22, 2023
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two DecadesMarie Ohbiki, Yuri Ito, Yoshihiro Inamoto, et al.
International Journal of Hematology|January 6, 2026
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotypeHiroki Yokoyama, Masamitsu Yanada, Shohei Mizuno, et al.
Cytotherapy|June 17, 2025
Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter studyShihomi Kuwano, Seitaro Terakura, Kanae Imai, et al.
Internal Medicine (Tokyo, Japan)|August 18, 2020
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera MyelofibrosisMakoto Murata, Ritsuro Suzuki, Tetsuya Nishida, et al.
Transplantation and Cellular Therapy|February 19, 2024
Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow TransplantationKodai Kuriyama, Shigeo Fuji, Ayumu Ito, et al.
Bone Marrow Transplantation|April 4, 2025
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimensTakuya Shimizu, Yasuyuki Arai, Tadakazu Kondo, et al.
Medicine|February 1, 2018
Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)Satoshi Nishiwaki, Isamu Sugiura, Yasuhiko Miyata, et al.
Pageof 17

Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
Blood Advances|March 20, 2020
Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantationSatoshi Kaito, Yujiro Nakajima, Konan Hara, et al.
British Journal of Haematology|October 20, 2025
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCTTomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, et al.
Plos One|September 26, 2017
High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotypeDaisuke Koyama, Makoto Murata, Ryo Hanajiri, et al.
Transplantation and Cellular Therapy|September 22, 2023
Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two DecadesMarie Ohbiki, Yuri Ito, Yoshihiro Inamoto, et al.
International Journal of Hematology|January 6, 2026
Prognostic factors influencing outcomes of allogeneic HCT for AML with monosomal karyotypeHiroki Yokoyama, Masamitsu Yanada, Shohei Mizuno, et al.
Cytotherapy|June 17, 2025
Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter studyShihomi Kuwano, Seitaro Terakura, Kanae Imai, et al.
Internal Medicine (Tokyo, Japan)|August 18, 2020
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera MyelofibrosisMakoto Murata, Ritsuro Suzuki, Tetsuya Nishida, et al.
Transplantation and Cellular Therapy|February 19, 2024
Impact of Different Fludarabine Doses in the Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow TransplantationKodai Kuriyama, Shigeo Fuji, Ayumu Ito, et al.
Bone Marrow Transplantation|April 4, 2025
Improved post-transplant outcomes for elderly acute myeloid leukemia patients conditioned with FLU/BU4 rather than conventional MAC regimensTakuya Shimizu, Yasuyuki Arai, Tadakazu Kondo, et al.
Medicine|February 1, 2018
Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)Satoshi Nishiwaki, Isamu Sugiura, Yasuhiko Miyata, et al.
Pageof 17